Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: United States Clear all

160 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20022
20032
20049
20057
200610
20073
20085
20095
20105
20114
20129
20134
20146
20154
20165
20175
20186
20195
20201
202115
20229
20235
20245
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83
Terminated27
Active, not recruiting23
Recruiting20
Unknown status5
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca19
Alliance for Clinical Trials in Oncology10
Eli Lilly and Company10
Novartis Pharmaceuticals7
Pfizer7
Sanofi5
Radiation Therapy Oncology Group4
AbbVie3
M.D. Anderson Cancer Center3
NRG Oncology3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis160
Breast Neoplasms38
Neoplasms29
Carcinoma, Non-Small-Cell Lung21
Prostatic Neoplasms15
Brain Neoplasms14
Colorectal Neoplasms12
Melanoma12
Carcinoma11
Carcinoma, Renal Cell8

Trials

Showing 1 to 25 of 160. Each trial links to its page on Pharma Observatory.

60 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.